Evaluation of tiamulin and lincomycin for the treatment of broiler breeders experimentally infected with the intestinal spirochaete Brachyspira pilosicoli.
Brachyspira pilosicoli strain CPSp1 isolated from a chicken in a broiler breeder flock in Queensland was used to experimentally infect 30 individually caged 22-week-old Cobb 500 broiler breeder hens. Another 10 birds were sham-inoculated with sterile broth. All birds failed to become colonized. At 29 weeks of age, all birds were transferred to a diet containing 50 parts/10(6) zinc bacitracin (ZnB) and were re-challenged with the same B. pilosicoli strain at 32 weeks of age, weekly for 5 weeks. The majority of the inoculated birds then became colonized, confirming previous findings that ZnB can increase susceptibility to colonization with B. pilosicoli. The control group remained uninfected. Infected groups tended to have an increased faecal water content and faecal staining of eggshells. Ten birds were then treated by crop tube with 25 mg/kg body weight tiamulin for 5 days, and 10 birds with 20 mg/kg body weight lincomycin for 5 days. Both treatments removed the infection, while untreated birds remained infected. The results support previous observations that ZnB at 50 parts/10(6) in the diet increases the susceptibility of birds to B. pilosicoli infection, and demonstrated the usefulness of both tiamulin and lincomycin for treatment of infection with B. pilosicoli in adult birds.
Stephens
C P
CP
Toowoomba Veterinary Laboratory, Animal and Plant Health Service, Department of Primary Industries, Toowoomba, Qld 4350, Australia.
Hampson
D J
DJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001414:Bacitracin / Q000008:administration & dosage / Q000378:metabolism; D002645:Chickens; D004198:Disease Susceptibility / Q000662:veterinary; D004224:Diterpenes / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D008034:Lincomycin / Q000494:pharmacology / Q000627:therapeutic use*; D010058:Oviposition / Q000187:drug effects; D011201:Poultry Diseases / Q000188:drug therapy* / Q000382:microbiology; D013144:Spirochaetales / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D013145:Spirochaetales Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*
D000900:Anti-Bacterial Agents; D004224:Diterpenes; D001414:Bacitracin; D008034:Lincomycin; C014224:tiamulin